Skip to search formSkip to main contentSkip to account menu

eviprostat

National Institutes of Health

Related topics

Related topics

5 relations
AltodorDicynone

Broader (3)

Drug CombinationsEthamsylatePlant Extracts

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Eviprostat Activates cAMP Signaling Pathway and Suppresses Bladder Smooth Muscle Cell Proliferation
Eviprostat is a popular phytotherapeutic agent for the treatment of lower urinary tract symptoms (LUTS). At present, the… 
2012
2012
Suppressive Effects of Eviprostat, a Phytotherapeutic Agent, on Lower Urinary Tract Symptoms in Prostate Cancer Patients Treated with Brachytherapy
Objectives: Eviprostat is an anti‐oxidant, anti‐inflammatory phytotherapeutic agent that is commonly used to treat lower urinary… 
2011
2011
Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis
Chronic inflammation in the prostate has recently been recognized as an important component of the symptom progression of benign… 
2011
2011
Effect of the phytotherapeutic agent Eviprostat on inflammatory changes and cytokine production in a rat model of nonbacterial prostatitis.
2008
2008
Mechanisms by which a phytotherapeutic drug influences bladder activity in rats.
2008
2008
[Assessment of clinical usefulness of Eviprostat for benign prostatic hyperplasia--comparison of Eviprostat tablet with a formulation containing two-times more active ingredients].
We compared the usefulness of Eviprostat tablet, a therapeutic agent for benign prostatic hyperplasia (BPH), and EVI-F tablet, a… 
2007
2007
Clinical and retrospective evaluation of eviprostat: A non-hormonal and non-neuropharmacological agent for benign prostatic hyperplasia
Eviprostat has been used as a non-hormonal and non-neuropharmacological treatment for benign prostatic hyperplasia (BPH) in Japan… 
2005
2005
[Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
OBJECTIVE To study the efficacy and safety of Eviprostat for the treatment of benign prostatic hyperplasia (BPH). METHODS An… 
2002
2002
Evidence‐based meta‐analysis of pharmacotherapy for benign prostatic hypertrophy
Evidence‐based diagnosis and treatment have been proposed recently in various medical fields. Evidence‐based diagnostic and… 
1983
1983
[Clinical effects of chlormadinone acetate (Prostal) on patients with prostatic hypertrophy--with reference to estimation of size and weight of prostate by means of transrectal ultrasonotomography].
Twenty patients with benign prostatic hypertrophy were treated with an anti-androgenic agent, chlormadinone acetate ( Prostal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)